Kiniksa Pharmaceuticals International PLC (KNSA)
21.01
-0.16
(-0.76%)
USD |
NASDAQ |
Dec 04, 13:46
Kiniksa Pharmaceuticals International Market Cap: 1.517B for Dec. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| December 03, 2024 | 1.529B |
| December 02, 2024 | 1.578B |
| November 29, 2024 | 1.594B |
| November 27, 2024 | 1.612B |
| November 26, 2024 | 1.591B |
| November 25, 2024 | 1.574B |
| November 22, 2024 | 1.536B |
| November 21, 2024 | 1.523B |
| November 20, 2024 | 1.531B |
| November 19, 2024 | 1.503B |
| November 18, 2024 | 1.552B |
| November 15, 2024 | 1.537B |
| November 14, 2024 | 1.575B |
| November 13, 2024 | 1.633B |
| November 12, 2024 | 1.660B |
| November 11, 2024 | 1.664B |
| November 08, 2024 | 1.651B |
| November 07, 2024 | 1.661B |
| November 06, 2024 | 1.663B |
| November 05, 2024 | 1.591B |
| November 04, 2024 | 1.551B |
| November 01, 2024 | 1.623B |
| October 31, 2024 | 1.631B |
| October 30, 2024 | 1.661B |
| October 29, 2024 | 1.680B |
| Date | Value |
|---|---|
| October 28, 2024 | 1.992B |
| October 25, 2024 | 1.981B |
| October 24, 2024 | 1.942B |
| October 23, 2024 | 1.937B |
| October 22, 2024 | 1.933B |
| October 21, 2024 | 1.868B |
| October 18, 2024 | 1.895B |
| October 17, 2024 | 1.930B |
| October 16, 2024 | 1.899B |
| October 15, 2024 | 1.953B |
| October 14, 2024 | 1.922B |
| October 11, 2024 | 1.917B |
| October 10, 2024 | 1.839B |
| October 09, 2024 | 1.799B |
| October 08, 2024 | 1.766B |
| October 07, 2024 | 1.712B |
| October 04, 2024 | 1.766B |
| October 03, 2024 | 1.753B |
| October 02, 2024 | 1.770B |
| October 01, 2024 | 1.838B |
| September 30, 2024 | 1.803B |
| September 27, 2024 | 1.781B |
| September 26, 2024 | 1.707B |
| September 25, 2024 | 1.717B |
| September 24, 2024 | 1.742B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
526.50M
Minimum
Jun 01 2022
1.992B
Maximum
Oct 28 2024
1.095B
Average
1.064B
Median
May 01 2020
Market Cap Benchmarks
| Pfizer Inc | 142.92B |
| NovaBay Pharmaceuticals Inc | 2.931M |
| Palatin Technologies Inc | 19.16M |
| iBio Inc | 24.15M |
| Theriva Biologics Inc | 3.673M |
Market Cap Related Metrics
| PS Ratio | 3.982 |
| PEG Ratio | -5.503 |
| Price to Book Value | 3.471 |
| Price to Free Cash Flow | 137.74 |
| Price | 21.01 |
| Earnings Yield | -0.67% |
| PEGY Ratio | -5.503 |